• Study Comparing Subcutaneous Pembrolizumab with Hyaluronidase to Intravenous Pembrolizumab and Chemotherapy for First-line Treatment of Metastatic Non-Small Cell Lung Cancer

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    France Hungary Poland Romania Spain

  • Study on Ritlecitinib for Adults and Adolescents with Nonsegmental Vitiligo

    Not recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    Bulgaria Germany Italy Poland Spain

  • Study on the V116 Vaccine for Adults Aged 18-64 at Increased Risk of Pneumococcal Infection

    Not recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    Poland

  • Study on Donanemab Dosing for Adults with Early Alzheimer’s Disease

    Not recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    Italy

  • Study on the Effects of Oral N-Acetylcysteine for Patients with Retinitis Pigmentosa

    Not recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    Austria Germany The Netherlands

  • Study on the Effectiveness of AP707, Gabapentin, and Capsaicin for Patients with Chronic Pain from Traumatic or Post-Operative Peripheral Neuropathy

    Not recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    Austria Germany

  • Study on REGN9933 for Preventing Blood Clots in Adults After Knee Replacement Surgery

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium Bulgaria Hungary Latvia Lithuania Poland

  • Study on the Effectiveness and Safety of AP707 with Lamotrigine and Amitriptyline for Patients with Chronic Central Neuropathic Pain

    Not recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    Austria Germany

  • Study on Starting Valsartan, Sacubitril, and Empagliflozin for Patients with Heart Failure with Reduced Ejection Fraction

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Portugal

  • Study on Reducing Proton Pump Inhibitor Use in Patients with Heartburn, Reflux, or Dyspepsia: Comparing On-Demand Use, Alginate Therapy, and Gradual Dose Reduction

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium

powered by